Benefit of cerebrolysin in brain injury patients

Benefit of cerebrolysin in head injury patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/04/003526

Enrollment

Registered

2013-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Brain injury

Interventions

Intervention1: cerebrolysin hydrolysate: cerebrolysin is administered at doses of 60mg in normal saline slow infusion over 60min two times a day for 10 days to be started on day 3 of brain injury. C

Eligibility

Inclusion criteria

Inclusion criteria: Brain injury patients with glasgow coma score of less than 10 at admission and age greater than 18 years and less than 60 years. CT scan brain should be available. Pre-injury Karnofsky score should be 100% Written and valid consent of relatives Medicine admnistered after 48 hours of the injury

Exclusion criteria

Exclusion criteria: less than 18 years or allergic/ hypersensitivity reaction to the medicine Pregnant patient pre-existing illness Alcohol dependancy

Design outcomes

Primary

Measure	Time frame
glasgow outcome score at 3 monthsTimepoint: glasgow outcome score at 3 months	—

Secondary

Measure	Time frame
noneTimepoint: none	—

Countries

India

Contacts

Public ContactPratyush Chaudhuri

nirmal balrugnalaya

pratyushchaudhuri@gmail.com9226711139

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026